Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fromm

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Digestive Diseases and Sciences|December 1, 1989
Bile acid-lipoprotein interactions: effects of ursodeoxycholic acid (ursodiol)H Fromm
Digestive Diseases and Sciences|December 1, 1989
Gallstone dissolution therapy with ursodiol. Patient selectionH Fromm
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Functional ileal disorders and signs of bacterial population of small intestine in regional enteritis (Crohn's disease)]H Fromm
Journal of Clinical Gastroenterology|January 1, 1988
Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstonesH Fromm
Gastroenterology|December 1, 1986
Gallstone dissolution therapy. Current status and future prospectsH Fromm
The Virginia Quarterly Review|January 1, 1979
Virginia Woolf: art and sexualityH Fromm
Endoscopy|May 1, 1992
ESWL: a method on retreat? I. Extracorporeal shock-wave lithotripsy (ESWL) plays an important role in the treatment of gallbladder stonesH Fromm
Gastroenterology|July 1, 1992
New treatment for primary sclerosing cholangitis: promising results with ursodiolH Fromm
Leber, Magen, Darm|June 1, 1977
[Celiac sprue (author's transl)]H Fromm
Gastroenterology|July 1, 1984
Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acidH Fromm
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Digestive Diseases and Sciences|December 1, 1989
Bile acid-lipoprotein interactions: effects of ursodeoxycholic acid (ursodiol)H Fromm
Digestive Diseases and Sciences|December 1, 1989
Gallstone dissolution therapy with ursodiol. Patient selectionH Fromm
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Functional ileal disorders and signs of bacterial population of small intestine in regional enteritis (Crohn's disease)]H Fromm
Journal of Clinical Gastroenterology|January 1, 1988
Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstonesH Fromm
Gastroenterology|December 1, 1986
Gallstone dissolution therapy. Current status and future prospectsH Fromm
The Virginia Quarterly Review|January 1, 1979
Virginia Woolf: art and sexualityH Fromm
Endoscopy|May 1, 1992
ESWL: a method on retreat? I. Extracorporeal shock-wave lithotripsy (ESWL) plays an important role in the treatment of gallbladder stonesH Fromm
Gastroenterology|July 1, 1992
New treatment for primary sclerosing cholangitis: promising results with ursodiolH Fromm
Leber, Magen, Darm|June 1, 1977
[Celiac sprue (author's transl)]H Fromm
Gastroenterology|July 1, 1984
Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acidH Fromm
Pageof 22